AGÕæÈ˹ٷ½

STOCK TITAN

[FWP] Morgan Stanley Free Writing Prospectus

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
FWP
Rhea-AI Filing Summary

Salesforce, Inc. (CRM) has filed a Form 144 signaling the intended sale of 144,000 common shares through Merrill Lynch on the NYSE around 01 July 2025. At the reference price used in the filing, the transaction is valued at approximately $39.24 million. The seller—whose name and relationship to Salesforce are not disclosed—originally obtained the shares on 22 March 2019 via the exercise of a stock option and paid for them in cash on 22 March 2023. No additional Salesforce shares have been sold by this filer during the past three months. The proposed sale represents roughly 0.015 % of the company’s 956 million shares outstanding, suggesting minimal impact on overall float or control. The filing contains no indication of a Rule 10b5-1 trading plan, nor any remarks beyond the standard certification language.

Salesforce, Inc. (CRM) ha presentato un Modulo 144 indicando la vendita prevista di 144.000 azioni ordinarie tramite Merrill Lynch alla NYSE intorno al 01 luglio 2025. Al prezzo di riferimento riportato nel modulo, l’operazione ha un valore di circa 39,24 milioni di dollari. Il venditore—il cui nome e rapporto con Salesforce non sono stati divulgati—ha originariamente acquisito le azioni il 22 marzo 2019 esercitando un’opzione azionaria e le ha pagate in contanti il 22 marzo 2023. Negli ultimi tre mesi questo soggetto non ha venduto ulteriori azioni Salesforce. La vendita proposta rappresenta circa lo 0,015% delle 956 milioni di azioni in circolazione, suggerendo un impatto minimo sulla flottante complessiva o sul controllo. Nel modulo non è indicata alcuna presenza di un piano di trading secondo la Regola 10b5-1, né commenti oltre al linguaggio standard di certificazione.

Salesforce, Inc. (CRM) ha presentado un Formulario 144 señalando la venta prevista de 144,000 acciones ordinarias a través de Merrill Lynch en la NYSE alrededor del 01 de julio de 2025. Al precio de referencia utilizado en la presentación, la transacción está valorada en aproximadamente 39,24 millones de dólares. El vendedor—cuyo nombre y relación con Salesforce no se divulgan—obtuvo originalmente las acciones el 22 de marzo de 2019 mediante el ejercicio de una opción sobre acciones y las pagó en efectivo el 22 de marzo de 2023. No se han vendido acciones adicionales de Salesforce por este declarante en los últimos tres meses. La venta propuesta representa aproximadamente el 0,015 % de las 956 millones de acciones en circulación, lo que sugiere un impacto mínimo en el flotante o control general. La presentación no indica la existencia de un plan de negociación según la Regla 10b5-1, ni comentarios más allá del lenguaje estándar de certificación.

Salesforce, Inc. (CRM)ëŠ� 2025ë…� 7ì›� 1ì¼ê²½ NYSEì� Merrill Lynchë¥� 통해 144,000ì£� 보통ì£� 매ê°ì� 예고하는 Form 144ë¥� 제출했습니다. ì œì¶œì„œì— ì‚¬ìš©ë� 기준 가격으ë¡� 거래 가치는 ì•� 3,924ë§� 달러ì—� 달합니다. íŒë§¤ìžëŠ” ì´ë¦„ê³� Salesforce와ì� 관계를 공개하지 않았으며, 해당 주ì‹ì€ 2019ë…� 3ì›� 22ì� 스톡옵션 행사ë¡� ì²˜ìŒ ì·¨ë“했으ë©� 2023ë…� 3ì›� 22ì� 현금으로 ëŒ€ê¸ˆì„ ì§€ë¶ˆí–ˆìŠµë‹ˆë‹�. ì§€ë‚� 3개월 ë™ì•ˆ ì� 제출ìžëŠ” 추가 Salesforce 주ì‹ì� 매ê°í•˜ì§€ 않았습니ë‹�. 제안ë� 매ê°ì€ 회사ì� 발행 ì£¼ì‹ 9ì–� 5,600ë§� ì£� ì¤� ì•� 0.015%ì—� 해당하여 ì „ì²´ 유통 주ì‹ì´ë‚˜ ì§€ë°°ì— ë¯¸ì¹˜ëŠ� ì˜í–¥ì� 미미í•� 것으ë¡� 보입니다. 제출서ì—ëŠ� Rule 10b5-1 거래 계íšì—� 대í•� 언급ì´ë‚˜ 표준 ì¸ì¦ 문구 ì™¸ì˜ ì¶”ê°€ 발언ì� 없습니다.

Salesforce, Inc. (CRM) a déposé un Formulaire 144 signalant la vente prévue de 144 000 actions ordinaires via Merrill Lynch à la NYSE autour du 1er juillet 2025. Au prix de référence utilisé dans le dépôt, la transaction est évaluée à environ 39,24 millions de dollars. Le vendeur—dont le nom et le lien avec Salesforce ne sont pas divulgués—a initialement obtenu les actions le 22 mars 2019 par l’exercice d’une option d’achat d’actions et les a payées en espèces le 22 mars 2023. Aucun autre titre Salesforce n’a été vendu par ce déclarant au cours des trois derniers mois. La vente proposée représente environ 0,015 % des 956 millions d’actions en circulation, suggérant un impact minimal sur le flottant global ou le contrôle. Le dépôt ne mentionne aucun plan de trading selon la règle 10b5-1, ni de remarques au-delà du langage standard de certification.

Salesforce, Inc. (CRM) hat ein Formular 144 eingereicht, das den beabsichtigten Verkauf von 144.000 Stammaktien über Merrill Lynch an der NYSE um den 01. Juli 2025 ankündigt. Zum im Formular angegebenen Referenzpreis wird die Transaktion auf etwa 39,24 Millionen US-Dollar geschätzt. Der Verkäufer—dessen Name und Beziehung zu Salesforce nicht offengelegt werden—erwarb die Aktien ursprünglich am 22. März 2019 durch Ausübung einer Aktienoption und bezahlte sie am 22. März 2023 in bar. In den letzten drei Monaten wurden von diesem Anmelder keine weiteren Salesforce-Aktien verkauft. Der vorgeschlagene Verkauf entspricht etwa 0,015 % der 956 Millionen ausstehenden Aktien des Unternehmens, was auf minimale Auswirkungen auf den Streubesitz oder die Kontrolle hindeutet. Das Formular enthält keinen Hinweis auf einen Rule 10b5-1 Handelsplan oder Bemerkungen über die standardmäßige Zertifizierungssprache hinaus.

Positive
  • None.
Negative
  • Proposed insider sale of 144,000 CRM shares worth $39.24 million, which could be viewed negatively from a sentiment standpoint despite its small proportional size.

Insights

TL;DR: $39 M insider sale equals 0.015 % of float—financially immaterial, sentiment neutral-to-slightly negative.

The Form 144 covers 144,000 CRM shares worth about $39 million. While the headline dollar amount is large, the stake is negligible versus Salesforce’s 956 million shares outstanding and should not influence liquidity or valuation. Lack of seller identity limits insight into potential strategic motives. Because no prior 3-month sales are reported, this appears to be a one-off disposal rather than a sustained exit. Overall, I view the filing as neutral from a fundamental perspective, with a modestly negative optical effect due to insider selling.

TL;DR: Anonymous Form 144 raises transparency concerns but scale of sale keeps impact limited.

The document omits the selling insider’s name and relationship to Salesforce, providing limited governance insight. Absence of a disclosed Rule 10b5-1 plan means investors cannot verify if the trade is pre-scheduled, which may elevate perception risk. Nonetheless, the 0.015 % stake is too small to alter control dynamics. Consequently, the filing is not materially impactful to governance standings, though disclosure quality could be improved.

Salesforce, Inc. (CRM) ha presentato un Modulo 144 indicando la vendita prevista di 144.000 azioni ordinarie tramite Merrill Lynch alla NYSE intorno al 01 luglio 2025. Al prezzo di riferimento riportato nel modulo, l’operazione ha un valore di circa 39,24 milioni di dollari. Il venditore—il cui nome e rapporto con Salesforce non sono stati divulgati—ha originariamente acquisito le azioni il 22 marzo 2019 esercitando un’opzione azionaria e le ha pagate in contanti il 22 marzo 2023. Negli ultimi tre mesi questo soggetto non ha venduto ulteriori azioni Salesforce. La vendita proposta rappresenta circa lo 0,015% delle 956 milioni di azioni in circolazione, suggerendo un impatto minimo sulla flottante complessiva o sul controllo. Nel modulo non è indicata alcuna presenza di un piano di trading secondo la Regola 10b5-1, né commenti oltre al linguaggio standard di certificazione.

Salesforce, Inc. (CRM) ha presentado un Formulario 144 señalando la venta prevista de 144,000 acciones ordinarias a través de Merrill Lynch en la NYSE alrededor del 01 de julio de 2025. Al precio de referencia utilizado en la presentación, la transacción está valorada en aproximadamente 39,24 millones de dólares. El vendedor—cuyo nombre y relación con Salesforce no se divulgan—obtuvo originalmente las acciones el 22 de marzo de 2019 mediante el ejercicio de una opción sobre acciones y las pagó en efectivo el 22 de marzo de 2023. No se han vendido acciones adicionales de Salesforce por este declarante en los últimos tres meses. La venta propuesta representa aproximadamente el 0,015 % de las 956 millones de acciones en circulación, lo que sugiere un impacto mínimo en el flotante o control general. La presentación no indica la existencia de un plan de negociación según la Regla 10b5-1, ni comentarios más allá del lenguaje estándar de certificación.

Salesforce, Inc. (CRM)ëŠ� 2025ë…� 7ì›� 1ì¼ê²½ NYSEì� Merrill Lynchë¥� 통해 144,000ì£� 보통ì£� 매ê°ì� 예고하는 Form 144ë¥� 제출했습니다. ì œì¶œì„œì— ì‚¬ìš©ë� 기준 가격으ë¡� 거래 가치는 ì•� 3,924ë§� 달러ì—� 달합니다. íŒë§¤ìžëŠ” ì´ë¦„ê³� Salesforce와ì� 관계를 공개하지 않았으며, 해당 주ì‹ì€ 2019ë…� 3ì›� 22ì� 스톡옵션 행사ë¡� ì²˜ìŒ ì·¨ë“했으ë©� 2023ë…� 3ì›� 22ì� 현금으로 ëŒ€ê¸ˆì„ ì§€ë¶ˆí–ˆìŠµë‹ˆë‹�. ì§€ë‚� 3개월 ë™ì•ˆ ì� 제출ìžëŠ” 추가 Salesforce 주ì‹ì� 매ê°í•˜ì§€ 않았습니ë‹�. 제안ë� 매ê°ì€ 회사ì� 발행 ì£¼ì‹ 9ì–� 5,600ë§� ì£� ì¤� ì•� 0.015%ì—� 해당하여 ì „ì²´ 유통 주ì‹ì´ë‚˜ ì§€ë°°ì— ë¯¸ì¹˜ëŠ� ì˜í–¥ì� 미미í•� 것으ë¡� 보입니다. 제출서ì—ëŠ� Rule 10b5-1 거래 계íšì—� 대í•� 언급ì´ë‚˜ 표준 ì¸ì¦ 문구 ì™¸ì˜ ì¶”ê°€ 발언ì� 없습니다.

Salesforce, Inc. (CRM) a déposé un Formulaire 144 signalant la vente prévue de 144 000 actions ordinaires via Merrill Lynch à la NYSE autour du 1er juillet 2025. Au prix de référence utilisé dans le dépôt, la transaction est évaluée à environ 39,24 millions de dollars. Le vendeur—dont le nom et le lien avec Salesforce ne sont pas divulgués—a initialement obtenu les actions le 22 mars 2019 par l’exercice d’une option d’achat d’actions et les a payées en espèces le 22 mars 2023. Aucun autre titre Salesforce n’a été vendu par ce déclarant au cours des trois derniers mois. La vente proposée représente environ 0,015 % des 956 millions d’actions en circulation, suggérant un impact minimal sur le flottant global ou le contrôle. Le dépôt ne mentionne aucun plan de trading selon la règle 10b5-1, ni de remarques au-delà du langage standard de certification.

Salesforce, Inc. (CRM) hat ein Formular 144 eingereicht, das den beabsichtigten Verkauf von 144.000 Stammaktien über Merrill Lynch an der NYSE um den 01. Juli 2025 ankündigt. Zum im Formular angegebenen Referenzpreis wird die Transaktion auf etwa 39,24 Millionen US-Dollar geschätzt. Der Verkäufer—dessen Name und Beziehung zu Salesforce nicht offengelegt werden—erwarb die Aktien ursprünglich am 22. März 2019 durch Ausübung einer Aktienoption und bezahlte sie am 22. März 2023 in bar. In den letzten drei Monaten wurden von diesem Anmelder keine weiteren Salesforce-Aktien verkauft. Der vorgeschlagene Verkauf entspricht etwa 0,015 % der 956 Millionen ausstehenden Aktien des Unternehmens, was auf minimale Auswirkungen auf den Streubesitz oder die Kontrolle hindeutet. Das Formular enthält keinen Hinweis auf einen Rule 10b5-1 Handelsplan oder Bemerkungen über die standardmäßige Zertifizierungssprache hinaus.

Free Writing Prospectus to Preliminary Pricing Supplement No. 9,100

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 1, 2025; Filed pursuant to Rule 433

Morgan Stanley

Worst-of SPX, NDX and RTY Buffered Jump Securities with Auto-Callable Feature due August 2, 2028

This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision.


Terms

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Underliers:

S&P 500® Index (SPX), Nasdaq-100 Index® (NDX) and Russell 2000® Index (RTY)

Automatic early redemption:

If, on the first determination date, the closing level of each underlier is greater than or equal to its call threshold level, the securities will be automatically redeemed for the early redemption payment. No further payments will be made on the securities once they have been automatically redeemed.

First determination date:

July 30, 2026

Call threshold level:

100% of the initial level for each underlier

Early redemption payment:

$1,090 to $1,110 per security

Participation rate:

150%

Buffer amount:

20% (80% maximum loss)1

Pricing date:

July 28, 2025

Final determination date:

July 28, 2028

Maturity date:

August 2, 2028

CUSIP:

61778NCW9

Estimated value:

$945.50 per security, or within $45.00 of that estimate

Preliminary pricing supplement:

https://www.sec.gov/Archives/edgar/data/895421/000183988225036148/ms9100_424b2-19778.htm

1All payments are subject to our credit risk

Hypothetical Payment at Maturity1

(if the securities have not been automatically redeemed prior to maturity)

% Change in Closing Level of the Worst Performing Underlier

Payment at Maturity (per Security)

+60.00%

$1,900.00

+40.00%

$1,600.00

+20.00%

$1,300.00

0.00%

$1,000.00

-20.00%

$1,000.00

-21.00%

$990.00

-40.00%

$800.00

-60.00%

$600.00

-80.00%

$400.00

-100.00%

$200.00


 

 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.

Underlier(s)

For more information about the underlier(s), including historical performance information, see the accompanying preliminary pricing supplement.

Risk Considerations

The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.

Risks Relating to an Investment in the Securities

The securities provide for only the minimum payment at maturity and do not pay interest.

If the securities are automatically redeemed prior to maturity, the appreciation potential of the securities is limited by the fixed early redemption payment specified for the first determination date.

The securities are subject to early redemption risk.

The market price of the securities may be influenced by many unpredictable factors.

The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices.

The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.

The securities will not be listed on any securities exchange and secondary trading may be limited.

As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

The U.S. federal income tax consequences of an investment in the securities are uncertain.

Risks Relating to the Underlier(s)

Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

oYou are exposed to the price risk of each underlier.

oBecause the securities are linked to the performance of the worst performing underlier, you are exposed to a greater risk of not receiving a positive return on the securities and/or sustaining a loss on your investment than if the securities were linked to just one underlier.

oAdjustments to an underlying index could adversely affect the value of the securities.

The securities are subject to risks associated with small-capitalization companies.

Risks Relating to Conflicts of Interest

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

Tax Considerations

You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption “Additional Information About the Securities–United States federal income tax considerations” concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax adviser.

 

FAQ

How many Salesforce (CRM) shares are being proposed for sale in this Form 144?

The filing covers 144,000 common shares.

What is the approximate market value of the proposed Salesforce share sale?

The aggregate market value listed is $39.24 million.

When is the planned sale date for the 144,000 CRM shares?

The filer indicates an approximate sale date of 01 July 2025.

What percentage of Salesforce’s outstanding shares does the sale represent?

The 144,000 shares equal roughly 0.015 % of the 956 million shares outstanding.

Were any Salesforce shares sold by this filer in the prior three months?

No; the section on past-3-month sales states "Nothing to Report."

How did the filer acquire the shares being sold?

The shares were acquired via a stock option exercise on 22 March 2019 and paid for in cash on 22 March 2023.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

224.20B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
United States
NEW YORK